Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 Malley Thomas Director Grant or award +12,922 46,696
2023-06-15 Malley Thomas Director Grant or award · Share Option (Right to Buy) +26,975 26,975
2022-06-22 Malley Thomas Director Grant or award +16,692 33,774
2022-06-22 Malley Thomas Director Grant or award · Share Option (Right to Buy) +34,645 34,645
2021-06-16 Malley Thomas Director Grant or award +7,800 17,082
2021-06-16 Malley Thomas Director Grant or award · Share Option (Right to Buy) +17,498 17,498
2020-06-17 Malley Thomas Director Grant or award · Share Option (Right to Buy) +45,383 45,383
2019-06-05 Malley Thomas Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2018-06-06 Malley Thomas Director Grant or award +9,290 9,290
2018-06-06 Malley Thomas Director Grant or award · Share Option (Right to Buy) +17,442 17,442
2017-06-02 Malley Thomas Director Grant or award · Share Option (Right to Buy) +169,988 169,988
2016-11-23 Malley Thomas Director Purchase +30,000 $32.00 $960K 30,000

Page 1 of 1 · 12 trades